Cargando…
Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders
Lysosomal storage diseases (LSDs) are a group of approximately 50 genetic disorders caused by mutations in genes coding enzymes that are involved in cell degradation and transferring lipids and other macromolecules. Accumulation of lipids and other macromolecules in lysosomes leads to the destructio...
Autores principales: | Issa, Shaza S., Shaimardanova, Alisa A., Valiullin, Victor V., Rizvanov, Albert A., Solovyeva, Valeriya V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8924473/ https://www.ncbi.nlm.nih.gov/pubmed/35308211 http://dx.doi.org/10.3389/fphar.2022.859516 |
Ejemplares similares
-
Gene Therapy of Sphingolipid Metabolic Disorders
por: Shaimardanova, Alisa A., et al.
Publicado: (2023) -
Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023) -
Safety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
por: Mullagulova, Aysilu, et al.
Publicado: (2023) -
Increasing β-hexosaminidase A activity using genetically modified mesenchymal stem cells
por: Shaimardanova, Alisa A., et al.
Publicado: (2023) -
Current Strategies for the Gene Therapy of Autosomal Recessive Congenital Ichthyosis and Other Types of Inherited Ichthyosis
por: Chulpanova, Daria S., et al.
Publicado: (2022)